Bennett P B, Valenzuela C, Chen L Q, Kallen R G
Department of Pharmacology, Vanderbilt University Medical School, Nashville, Tenn 37232, USA.
Circ Res. 1995 Sep;77(3):584-92. doi: 10.1161/01.res.77.3.584.
The mechanism of inhibition of Na+ channels by lidocaine has been suggested to involve low-affinity binding to rested states and high-affinity binding to the inactivated state of the channel, implying either multiple receptor sites or allosteric modulation of receptor affinity. Alternatively, the lidocaine receptor may be guarded by the channel gates. To test these distinct hypotheses, inhibition of Na+ channels by lidocaine was studied by voltage-clamp methods in both native and heterologous expression systems. Native Na+ channels were studied in guinea pig ventricular myocytes, and recombinant human heart Na+ channels were expressed in Xenopus laevis oocytes. Fast inactivation was eliminated by mutating three amino acids (isoleucine, phenylalanine, and methionine) in the III-IV interdomain to glutamines or by enzymatic digestion with alpha-chymotrypsin. In channels with intact fast inactivation, lidocaine block developed with a time constant of 589 +/- 42 ms (n = 7) at membrane potentials between -50 and +20 mV, as measured by use of twin pulse protocols. The IC50 was 36 +/- 1.8 mumol/L. Control channels inactivated within 20 ms, and slow inactivation developed much later (time constant of slow inactivation, 6.2 +/- 0.36 s). The major component of block developed long after activated and open channels were no longer available for drug binding. Control channels recovered fully from inactivation in < 50 ms at -120 mV (time constant, 11 +/- 0.5 ms; n = 50).(ABSTRACT TRUNCATED AT 250 WORDS)
利多卡因抑制钠通道的机制被认为涉及与通道静息态的低亲和力结合以及与失活态的高亲和力结合,这意味着存在多个受体位点或受体亲和力的变构调节。另外,利多卡因受体可能受通道门控。为了验证这些不同的假说,采用电压钳技术在天然和异源表达系统中研究了利多卡因对钠通道的抑制作用。在豚鼠心室肌细胞中研究天然钠通道,在非洲爪蟾卵母细胞中表达重组人心脏钠通道。通过将III-IV结构域中的三个氨基酸(异亮氨酸、苯丙氨酸和甲硫氨酸)突变为谷氨酰胺或用α-糜蛋白酶进行酶切来消除快速失活。在具有完整快速失活的通道中,使用双脉冲方案测量,在-50至+20 mV的膜电位下,利多卡因阻滞的发展时间常数为589±42 ms(n = 7)。IC50为36±1.8 μmol/L。对照通道在20 ms内失活,缓慢失活则在很久之后出现(缓慢失活的时间常数为6.2±0.36 s)。阻滞的主要成分在激活和开放的通道不再可供药物结合很久之后才出现。对照通道在-120 mV时在<50 ms内完全从失活中恢复(时间常数为11±0.5 ms;n = 50)。(摘要截短于250字)